Skip to content
MatchScript
Menu
Ranked #9 · Grade B−Editorial review

Henry Meds review

A flat-fee compounded pioneer — simple, transparent model, but priced at the higher end now.

Visit Henry Meds Editorial review — no commercial relationship.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

The factor breakdown

Henry Meds scored on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.

Budget Fit72/100
Speed to Start84/100
Formulary Match80/100
Support Level84/100
Flexibility86/100
Transparency86/100

What we like

  • Simple, transparent flat-fee model
  • Well-established brand
  • Both molecules

The caveats

  • Higher pricing than many newer entrants
  • Compounded only

Who it matches

Best for: People who want a simple, well-known flat-fee compounded program. A flat-fee compounded pioneer — simple, transparent model, but priced at the higher end now.

Ranked #9 of 9 providers under our default weighting — see our #1 pick, CoreAge Rx, or take the quiz to see where Henry Meds lands for you.

Compare with other providers

All 8 other providers we've reviewed, in our default ranking order.

Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Match Score is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to all rankings